Bikard D - Search Results

1

Cas9 specifies functional viral targets during CRISPR-Cas adaptation.

Heler R, Samai P, Modell JW, Weiner C, Goldberg GW, Bikard D, Marraffini LA. Heler R, et al. Among authors: bikard d. Nature. 2015 Mar 12;519(7542):199-202. doi: 10.1038/nature14245. Epub 2015 Feb 18. Nature. 2015. PMID: 25707807 Free PMC article.

2

Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages.

Bikard D, Marraffini LA. Bikard D, et al. Curr Opin Immunol. 2012 Feb;24(1):15-20. doi: 10.1016/j.coi.2011.10.005. Epub 2011 Nov 11. Curr Opin Immunol. 2012. PMID: 22079134 Review.

3

CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection.

Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA. Bikard D, et al. Cell Host Microbe. 2012 Aug 16;12(2):177-86. doi: 10.1016/j.chom.2012.06.003. Cell Host Microbe. 2012. PMID: 22901538 Free article.

4

RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. Jiang W, et al. Among authors: bikard d. Nat Biotechnol. 2013 Mar;31(3):233-9. doi: 10.1038/nbt.2508. Epub 2013 Jan 29. Nat Biotechnol. 2013. PMID: 23360965 Free PMC article.

5

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system.

Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. Bikard D, et al. Nucleic Acids Res. 2013 Aug;41(15):7429-37. doi: 10.1093/nar/gkt520. Epub 2013 Jun 12. Nucleic Acids Res. 2013. PMID: 23761437 Free PMC article.

6

Control of gene expression by CRISPR-Cas systems.

Bikard D, Marraffini LA. Bikard D, et al. F1000Prime Rep. 2013 Nov 1;5:47. doi: 10.12703/P5-47. eCollection 2013. F1000Prime Rep. 2013. PMID: 24273648 Free PMC article. Review.

7

Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.

Heler R, Marraffini LA, Bikard D. Heler R, et al. Among authors: bikard d. Mol Microbiol. 2014 Jul;93(1):1-9. doi: 10.1111/mmi.12640. Epub 2014 Jun 4. Mol Microbiol. 2014. PMID: 24806524 Free PMC article. Review.

8

Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.

Goldberg GW, Jiang W, Bikard D, Marraffini LA. Goldberg GW, et al. Among authors: bikard d. Nature. 2014 Oct 30;514(7524):633-7. doi: 10.1038/nature13637. Epub 2014 Aug 31. Nature. 2014. PMID: 25174707 Free PMC article.

9

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, Fischetti VA, Marraffini LA. Bikard D, et al. Nat Biotechnol. 2014 Nov;32(11):1146-50. doi: 10.1038/nbt.3043. Epub 2014 Oct 5. Nat Biotechnol. 2014. PMID: 25282355 Free PMC article.

10

Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.

Maniv I, Jiang W, Bikard D, Marraffini LA. Maniv I, et al. Among authors: bikard d. J Bacteriol. 2016 Jan 11;198(6):941-50. doi: 10.1128/JB.00897-15. J Bacteriol. 2016. PMID: 26755632 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page